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Conclusions: Statistically signiﬁcant improvements to 3He-MRI to 
planning CT image registration can be achieved by using a dedicated 
imaging protocol that enables both 3He-MRI and planning CT to be 
acquired with similar breath holds and body position. Improved image 
registration accuracy will be beneﬁcial when performing functionally-
weighted IMRT planning.
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Background: We have previously reported that tumor opacity in 
the mediastinal window image in thin-section CT (TS-CT) is associ-
ated with prognosis of lung adenocarcinoma of 20 mm or smaller in 
diameter. However, pathological investigation of the tumor opacity in 
the mediastinal window has not been performed in detail. To investi-
gate the relationship between imaging and pathological ﬁndings, the 
solid lesion in the pathological preparation observed under a magnify-
ing glass (SLP) and tumor opacity in the mediastinal window image 
(TOM) in TS-CT were compared. The relationships of SLP and TOM 
with relapse were also investigated. 
Methods: The subjects were 115 patients with a lung adenocarcinoma 
of 20 mm or smaller in diameter who underwent surgical resection at 
the Kanagawa Cancer Center between January 1997 and October 2003. 
Pathological and imaging ﬁndings for these patients were re-investigat-
ed in this study. Patients with bronchioloalveolar carcinoma (BAC) that 
was undetectable in the mediastinal window image were excluded. SLP 
was deﬁned as follows: 1) regions with alveolar collapse, 2) regions 
accompanied by destruction of the alveolar framework, and 3) regions 
described in 2) accompanied by collagen ﬁbrotic foci. The maximum 
diameters of the tumor and SLP were measured in the pathological 
preparation, and the proportion of the maximum diameter of the SLP to 
the maximum tumor diameter was calculated as the pathological ratio. 
In TS-CT, the proportion of the reduction in the TOM maximum diam-
eter to the maximum diameter of the tumor opacity in the lung window 
was calculated as the reduction percentage. Correlations between the 
maximum SLP and TOM diameters and between the pathological ratio 
and the reduction percentage were investigated, and the association of 
relapse with SLP, TOM, the pathological ratio, and reduction percent-
age was also examined. 
Results: Strong Pearson correlations were noted between the maximum 
TOM and SLP diameters (correlation coefﬁcient: 0.852, p<0.0001) and 
between the reduction percentage and pathological ratio (correlation 
coefﬁcient: 0.895, p<0.0001). The maximum TOM and SLP diameters 
were not signiﬁcantly associated with relapse. However, the incidence 
of relapse was signiﬁcantly higher in patients with a reduction percent-
age of less than 50% by log-rank test; no relapse occurred in patients 
with a reduction percentage of 50% or higher. Similarly, the incidence 
of relapse was signiﬁcantly higher in patients with a pathological ratio 
of less than 50% by log-rank test; no relapse occurred in patients with a 
pathological ratio of 50% or higher in the pathological preparation. 
Conclusions: Use of the reduction percentage in TS-CT to classify 
lesions into two groups with different prognoses is valid based on the 
pathological investigation. Therefore, measurement of the reduction 
percentage and pathological ratio may allow prediction of cases of 
small adenocarcinoma of the lung with a good prognosis.
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Background: Response evaluation criteria in solid tumor (RECIST) is 
widely used as a standard method for evaluation of tumor response in 
clinical oncology. RECIST is based on uni-dimensional measurement 
of target lesions and is simpler than WHO criteria which are based on 
bi-dimensional measurement. In clinical practice, we sometimes use 
serum tumor markers to estimate tumor response as well, particularly 
when measurement of tumor size is difﬁcult. The aim of this study is to 
compare WHO criteria, RECIST, and serum carcinoembryonic antigen 
(CEA) level for evaluating tumor response to chemotherapy in non-
small cell lung cancer (NSCLC).
Patients and Methods: During an 11-year period from 1995 through 
2005, 24 NSCLC patients with high serum CEA level (> 5ng/ml) at 
presentation were retrospectively analyzed. They underwent pulmonary 
resection after induction chemotherapy. In each case, we compared 
histological response of tumor response of resected specimens.
Results: Using WHO criteria, nine and 15 patients achieved partial re-
sponse (PR) and no change (NC), respectively. With RECIST, PR was 
seen in 11 patients, stable disease (SD) in 13. Concordance between 
WHO and RECIST was 83 %. When we compare CEA level before 
chemotherapy with that obtained after chemotherapy, CEA levels 
signiﬁcantly decreased in PR group deﬁned by WHO criteria [26.3 
(median) ng/ml to 4.3 ng/ml, P = 0.008, wilcoxon t test] or RECIST 
[17.3 ng/ml to 4.4 ng/ml, P = 0.004, wilcoxon t test ]. On the contrary, 
in patients whose responses were NC or SD, there was no signiﬁcant 
difference [16.8 ng/ml to 9.9 ng/ml, P = 0.24, 16.8ng/ml to 19.6 ng/ml, 
P = 0.24, respectively]. In comparison of CEA level with histologic re-
sponse, CEA decreased signiﬁcantly in patients in whom less than one-
third of tumor cells were viable [17.3 ng/ml to 4.4 ng/ml, P = 0.008, 
wilcoxon t test] but not in whom more than two thirds of tumor cells 
were viable [16.8 ng/ml to 7.9 ng/ml, P = 0.06, wilcoxon t test]. From 
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the receiver operating characteristic curve analysis, 60% reduction of 
CEA level should be an appropriate cut-off value in predicting good 
response to the chemotherapy. In this condition, the sensitivity and 
spescifciity of CEA for RECIST were 82.8% and 69.2%, respectively.
Conclusions: Determination of changes in serum CEA level appeared 
to be useful as an surrogate index for evaluation of tumor response to 
chemotherapy that would result in comparable judgment with RECIST 
in patients with NSCLC who had elevated CEA level before treatment.
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Background: Although there have been many controversies in lung 
cancer screening, low-dose CT (LDCT) is currently used in clinical 
research studies or even in practice in many countries. There are few 
reports about lung cancer screening with LDCT from Asia except 
Japan.
Materials and Methods: Between May 2001 and February 2006, a 
total of 11,974 asymptomatic adults (≥ 40 years) who underwent LDCT 
for lung cancer screening were retrospectively analyzed. We assessed 
overall detection rates, demographic ﬁndings, staging, histology, and 
CT ﬁndings of lung cancers found on LDCT. 
Results: There were 6,612 men and 5,362 women with age range from 
40 to 92 years (mean, 53.7±8.2 years). Lung cancers were detected in 
25 individuals (0.21%) either initial (n=20) or annual follow-up LDCT 
(n=5). They were 12 men and 13 women with age range from 45 to 
73 years (mean, 58±8 years). Fifteen patients were non-smokers and 
10 were smokers. They were all non-small cell cancer (16 stage IA, 5 
stage IB, 1 stage II, and 3 stage IIIA) with the histology of bronchio-
loalveolar carcinoma (BAC, n=8), adenocarcinoma (n=14), squamous 
cell (n=2) and large cell carcinoma (n=1). Twenty-six lesions in 24 
patients appeared as a nodule with ground-glass opacity (GGO, n=5), 
mixed GGO (n=9) or solid (n=12) with mean size of 17.6±6.7 mm 
(range, 5-36 mm) while only one as endobronchial mass. The histologic 
type of GGO or mixed GGO nodule was BAC or adenocarcinoma 
with BAC features. Four BAC appeared as solid nodules. Details of 
four symptom-diagnosed cancers were given in Table 1. They were all 
smokers.
Patient Sex
Age 
(years)
Histology Stage
Interval 
(months)
Findings in 
initial LDCT
1 M 53 Squamous IB 8 Focal bronchial thickening
2 M 54 NSCLC IV 30 Peripheral solid nodule (7mm)
3 M 56 Adeno, PD IIIB 37 Subtle hilar bulging
4 M 46 Adeno, PD IV 29 Normal even on retrospect
Conclusion: The overall detection rate was 0.21% in LDCT screening 
of asymptomatic adults older than 40 years. Most of screen-detected 
lung cancers were stage I (84%) with histology of adenocarcinoma 
including BAC. More than 90% of screen detected lung cancers were 
appeared as a peripheral nodule with either GGO, mixed or solid. 
Symptom-detected lung cancers were more aggressive and could be 
unrecognized since they are located in central on initial LDCT scans. 
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Background: Bronchioloalveolar cell carcinoma (BAC) component 
is a prognostic indicator and well correlated with GGO area on HRCT. 
However, it does not always appeared as GGO area. The purpose of our 
study was to determine the histologic ﬁndings of non-GGO area when 
there is discrepancy between the area of GGO on CT and BAC area on 
histopathology.
Materials and Methods: The subjects were 66 patients with BAC and 
adenocarcinoma with BAC feature smaller than 3 cm in largest diam-
eter in who underwent lung resection between March 2001 and June 
2004. They were 29 men and 37 women with mean age of 62.1 years 
(range, 42 - 82 years). The extent of the GGO of nodule was classiﬁed 
into grade 1 (≤50%), grade 2 (50-90%), and grade 3 (≥90%) accord-
ing to tumor disappearance rate (TDR %) in section with maximal 
diameter of the nodule on HRCT. TDR % was deﬁned as [1 - (maximal 
diameter×perpendicular diameter on mediastinal windows/maximal 
diameter×perpendicular diameter on lung windows)] ×100. One pa-
thologist retrospectively reviewed the extent of area of BAC classiﬁed 
into grade 1 (≤50%), grade 2 (50-90%), and grade 3 (≥90%) without 
knowledge of CT results on representative section of pathologic slide. 
When there is discrepancy the grade between CT and pathologic slide, 
slides were reviewed further evaluation of other histologic ﬁndings in 
BAC area.
Results: The relationship between TDR and Histologic BAC% was 
given in Table 1.
Table 1: BAC % correlated with TDR (p<0.0001, Kruskal-Wallis test) 
BAC%/TDR% 1 2 3 Total
1 27 2  31
2 14 4  18
3 6 (2)* 4 (2)* 9 (4)* 19
Total 47 4 9 66
* numbers in parenthesis are pure BAC.HRCT underestimated BAC component in 24 cases and overes-
timated in two cases. The histologic components producing underestimation of BAC component were 
lymphocytic inﬁltration with or without intraalveolar macrophage (n=8), Aleolar collapse (n=6), mucin 
in alveolar space (n=4) and intraalveolar macrophage (n=3), etc. Overestimation of BAC component was 
related to intratumoral lucencies in two cases. 
Conclusion: BAC % was correlated with ground-glass opacity area on 
HRCT. BAC component did not always appear as ground-glass opacity 
on HRCT. Underestimation of BAC component on HRCT was related 
to lymphocytic inﬁltration in interstitium, intraalveolar macrophage and 
mucin in alveolar space and alveolar collapse.
